ClearPoint Neuro to commercialize FDA-cleared neuro laser

The ClearPoint Prism neuro laser therapy system [Image courtesy of ClearPoint Neuro]ClearPoint Neuro (Nasdaq: CLPT) announced today that FDA has cleared its Swedish partner Clinical Laserthermia Systems’ neuro laser therapy system.

The plan is for ClearPoint Neuro to commercialize the system as the ClearPoint Prism. The company has exclusive global rights to commercialize the CLS magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) system. The system is for neuro applications.

The ClearPoint Neuro navigation system has FDA clearance and a CE mark. The company has it installed in over 60 active sites in the United States, Canada, and Europe. In addition, the company has partnerships with more than 45 pharmaceutical and biotech companies. Applications it’s pursuing include drug delivery to the brain. Also, ClearPoint Neuro is active in the hot brain-computer interface space. It is working with Blackrock Neurotech to automate BCI im…

Read more
  • 0